Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care System

ABSTRACT Objective: Lung cancer is an important health problem due to its high incidence and mortality. The treatment of metastatic disease improved after the molecular pathways of cancer came to be known. However, targeted therapy is unavailable to many patients treated within the Brazilian Sistem...

Full description

Bibliographic Details
Main Authors: Pedro Aguiar Jr, Felipe Roitberg, Gilberto Lopes Jr, Auro del Giglio
Format: Article
Language:English
Published: Sociedade Brasileira de Pneumologia e Tisiologia
Series:Jornal Brasileiro de Pneumologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132020000400206&lng=en&tlng=en